发明名称 CD44V6 peptides as inhibitors of bacterial infections
摘要 A method for treatment of infection with Listeria spp., Plasmodium spp., or Shigella spp. includes administering a peptide or a pharmaceutically acceptable salt of the peptide to an individual in need of treatment for the infection.
申请公布号 US8933017(B2) 申请公布日期 2015.01.13
申请号 US201213673749 申请日期 2012.11.09
申请人 Karlsruher Institut fur Technologie 发明人 Jung Christian;Orian-Rousseau Véronique;Matzke Alexandra;Ponta Helmut
分类号 A61K38/12;A61K38/10;A61K38/04;A61K38/08;C07K7/08;C07K7/00;C07K5/12;A61K38/17;C07K14/705 主分类号 A61K38/12
代理机构 Knobbe, Martens, Olson & Bear, LLP 代理人 Knobbe, Martens, Olson & Bear, LLP
主权项 1. A method for treatment of a bacterial infection in an individual comprising: administering to an individual in need of treatment of bacterial infection a peptide compound comprising the amino acid sequence set forth in amino acids 7 to 11 of SEQ ID NO: 2, or a pharmaceutically acceptable salt of said peptide in an amount of about 0.01 to about 1000 mg of per kg body weight of a subject per day throughout a course of treatment effective to treat the bacterial infection, wherein the bacterial infection is an infection with an intracellular bacterium selected from the group consisting of Listeria spp., Plasmodium spp., and Shigella spp.
地址 Karlsruhe DE